Invention Grant
- Patent Title: Carboxy substituted glucocorticoid receptor agonists
-
Application No.: US17700824Application Date: 2022-03-22
-
Publication No.: US11618767B2Publication Date: 2023-04-04
- Inventor: Ryan Edward Stites , Jacqueline Mary Wurst
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Gabriel Magallanes
- Main IPC: C07J71/00
- IPC: C07J71/00

Abstract:
The present invention provides a compound of Formula I: wherein R1 is H, halogen, C1-C3 alkyl, or C1-C3 alkoxy; R2 is H or halogen; and X is O, OCH2, or CH2, or a pharmaceutically acceptable salt thereof, wherein the compound of Formula I, or pharmaceutically acceptable salt thereof is useful for treating autoimmune and inflammatory diseases, such as atopic dermatitis, rheumatoid arthritis, and lupus nephritis.
Public/Granted literature
- US20220306681A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS Public/Granted day:2022-09-29
Information query